Clinical Trials Browser

Phase 3 × INDUSTRY × rofecoxib × Clear all

NCT00060476 2017-05-09

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

Phase 3 Completed

15,000 enrolled

Prostatic Neoplasms